Last Update Time:
18-Mar-2025 16:00:00
ISIN:
INE075I01017
Sector:
Healthcare
Symbol:
HCG
Healthcare Global Enterprises Limited
₹497.10
₹-0.90
(-0.18%)
▼
Prev. Close
₹498.00
Open
₹495.35
Close
₹498.75
Range
₹472.25 - ₹521.96
High
₹500.00
Low
₹495.35
Ind. Close
₹0.00
VWAP
₹498.67
The current stock price of Healthcare Global Enterprises Limited is ₹497.10, with a target price range between ₹472.25 and ₹521.96. The stock has experienced a price change of ₹-0.90 (-0.18%), reflecting recent market volatility.
Today's opening price was ₹495.35, while the previous close stood at ₹498.00.
The market trend suggests a potential downtrend, with investors exercising caution due to recent declines. Analysts recommend closely monitoring support levels.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Healthcare Global Enterprises Limited Price Chart
Healthcare Global Enterprises Limited Pre Open Market Overview: 18-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 495.35
- Previous Close Price: 498
- Change: -2.65%
- Total Traded Volume: 59
- Total Buy Quantity: 37,604
- Total Sell Quantity: 41,483
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 493.05 | 2,005.00 | 0.00 |
| 494.00 | 1.00 | 0.00 |
| 495.00 | 20,102.00 | 0.00 |
| 495.05 | 1,000.00 | 0.00 |
| 495.35 | 498.00 | 0.00 |
| 497.00 | 0.00 | 23.00 |
| 498.00 | 0.00 | 45.00 |
| 500.00 | 0.00 | 822.00 |
| 503.95 | 0.00 | 47.00 |
| 504.05 | 0.00 | 27.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 37604
Total Sell Quantity: 41483
Shareholding Patterns of Healthcare Global Enterprises Limited
Key Trade Statistics of Healthcare Global Enterprises Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 1.20 |
| Traded Value (₹ Cr.) | 6.01 |
| Total Market Cap (₹ Cr.) | 6,930.34 |
| Free Float Market Cap (₹ Cr.) | 1,985.32 |
| Impact cost | 0.11 |
| Quantity Traded | 120,439.00 |
| Deliverable Quantity | 78,848.00 |
| % of Quantity to Traded | 65.47 |
| Security VaR | 12.56 |
| Index VaR | N/A |
| VaR Margin | 12.56 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 16.06 |
| Face Value | 10 |
Key Price Statistics of Healthcare Global Enterprises Limited
The 52-week high for Healthcare Global Enterprises Limited was ₹567.70, recorded on 03-Feb-2025. On the other hand, the 52-week low stands at ₹326.00, with the lowest value recorded on 27-Mar-2024.
The upper band for trading is ₹597.60, and the lower band is ₹398.40. The price band is 20%.
The stock's daily volatility stands at 1.97, while the annualized volatility is 37.64. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (03-Feb-2025) | 567.70 |
| 52 Week Low (27-Mar-2024) | 326.00 |
| Upper Band | 597.60 |
| Lower Band | 398.40 |
| Price Band (%) | 20 |
| Daily Volatility | 1.97 |
| Annualised Volatility | 37.64 |
| Tick Size | 0.05 |
Key Securities Statistics of Healthcare Global Enterprises Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 30-Mar-2016 |
| Adjusted P/E | 112.44 |
| Symbol P/E | 107.48 |
| Index | NIFTY TOTAL MARKET |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Healthcare Services |
| Basic Industry | Hospital |
Security Status of Healthcare Global Enterprises Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Healthcare Global Enterprises Limited
| Subject | Date |
|---|---|
| General Updates | 17-Mar-2025 |
| General Updates | 11-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 06-Mar-2025 |
| Updates | 03-Mar-2025 |
| Public Announcement-Open Offer | 03-Mar-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 27-Feb-2025 |
| Analysts/Institutional Investor Meet/Con. Call Updates | 25-Feb-2025 |
| Integrated Filing- Financial | 24-Feb-2025 |
Corporate Actions of Healthcare Global Enterprises Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 10 | Annual General Meeting | 22-Sep-2022 |
| 10 | Annual General Meeting | 23-Sep-2021 |
| 10 | Annual General Meeting | 19-Sep-2019 |
| 10 | Annual General Meeting | 19-Sep-2018 |
| 10 | Annual General Meeting | 03-Aug-2017 |
| 10 | Annual General Meeting | 22-Sep-2016 |
Board Meetings of Healthcare Global Enterprises Limited
Financial Results of Healthcare Global Enterprises Limited
Company Directory of Healthcare Global Enterprises Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| www.hcgoncology.com | Head Office/ Corporate Office | TOWER BLOCK, UNITY BUILDING COMPLEX NO. 3, MISSION ROAD |
BANGALORE |
| www.hcgoncology.com | Registered Office | HCG Tower, No. 8, P Kalinga Rao Road Sampangi Rama Nagar Bengaluru 560 027 |
BANGALORE |
Insider Trading of Healthcare Global Enterprises Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | Dr B S Ajaikumar | 946269500 | Pledge |
| 7(2) | Madan Kumar Sampath | 1546350 | Sell |
| 7(2) | Venkataramanan P | 365115 | Sell |
| 7(2) | Venkataramanan P | 2855798 | Sell |
| 7(2) | Lakshman T L | 1028000 | Sell |
| 7(2) | BOMANAHALLI RANGASWAMAIAH GIRISH | 1024000 | Sell |
| 7(2) | Roshan | 5250 | Buy |
| 7(2) | Dr Navin Chugh | 3000 | Buy |
| 7(2) | Lakshman T L | 6000 | Buy |
| 7(2) | Prateek Jain | 10870 | Buy |
| 7(2) | Narayanan V | 4500 | Buy |
| 7(2) | BOMANAHALLI RANGASWAMAIAH GIRISH | 1500 | Buy |
| 7(2) | Dr Amarjeet Singh | 3750 | Buy |
| 7(2) | Vijay S Shanbhag | 3750 | Buy |
| 7(2) | Asha Nagaraj | 1500 | Buy |
| 7(2) | Yuva Kishore Terli | 2250 | Buy |
| 7(2) | Ashutosh Kumar | 50000 | Buy |
| 7(2) | Ashwini P K | 3750 | Buy |
| 7(2) | Dr Aditya Kaura | 6000 | Buy |
| 7(2) | Varun Mishra | 2088000 | Sell |
Annual Reports of Healthcare Global Enterprises Limited
Investor Complaints of Healthcare Global Enterprises Limited
Event Calendar of Healthcare Global Enterprises Limited
| Purpose | Details |
|---|---|
| Results/Others | inter-alia to consider, approve and take on record the Audited Financials Results (both Standalone & Consolidated) of the Company for the quarter and the year ended March 31, 2016. |
| Results | Inter-alia to consider, approve and take on record the Unaudited Financial Results (both Standalone & Consolidated) of the Company for the quarter ended June 30, 2016. |
| Results | inter-alia to consider, approve and take on record the Unaudited Financial Results (both Standalone & Consolidated) of the Company for the quarter and half year ended on September 30, 2016. |
| Results/Others | inter-alia to: 1) Consider, approve and take on record the Unaudited Financial Results (both Standalone & Consolidated) of the Company for the quarter and nine months ended on December 31, 2016. 2) Approve issue and allot equity shares of the Company under Employee Stock Option Scheme of the Company. |
| Results | Inter-alia to: 1. Consider, approve and take on record the Audited Financial Results (both Standalone & Consolidated) of the Company for the quarter and financial year ended on March 31, 2017. 2. Auditors Report on the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended on March 31, 2017. |
| Results | Inter-alia to consider, approve and take on record the unaudited Financial Results (both Standalone & Consolidated) of the Company for the quarter ended on June 30, 2017. |
| Results/Others | The Company had informed the Exchange regarding the meeting of the Board of Directors of the Company scheduled to be held on November 07, 2017 inter-alia to consider, approve and take on record the unaudited Financial Results (both Standalone & Consolidated) of the Company for the quarter and half year ended on September 30, 2017. The Company has now informed the Exchange that the Board of Directors of the Company at the said meeting, would inter-alia consider a proposal for issuance of Equity Shares of the Company on a Preferential basis.(Purpose Revised) |
| Results | Inter-alia to consider, approve and take on record the unaudited Financial Results (both Standalone & Consolidated) of the Company for the quarter and half year ended on September 30, 2017. |
| Preferential issue | inter-alia to consider a proposal for issuance of Equity Shares of the Company on Preferential basis. |
| Results | Inter-alia to consider, approve and take on record the unaudited Financial Results (both Standalone & Consolidated) of the Company for the quarter and nine months ended on December 31, 2017. |
| Results/Others | ￂﾠThe Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held February 08, 2018,ￂﾠInter-alia to consider, approve and take on record the unaudited Financial Results (both Standalone & Consolidated) of the Company for the quarter and nine months ended on December 31, 2017.ￂﾠThe Company has now informed the Exchange that theￂﾠBoard of Directors of the Company at the said meeting, would inter-alia consider the following: i) proposal for issuance of Equity Shares of the Company on a Preferential basis to a Promoter; and ii) consider and approve issue and allotment of equity shares of the Company to employees of the Company exercising stock options under Employee Stock Option Scheme of the Company. (Purpose Revised) |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2018 |
| Financial Results | To consider and approve the financial results for the quarter ended Jun 30, 2018 |
| Financial Results | To consider and approve the financial results for the period ended September 30, 2018 |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2018 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2019 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2019 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2019 and other business matters |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2019 |
| Fund Raising | Notice is hereby given that the meeting of the Board of Directors of the Company is scheduled for Thursday, May 07, 2020, at Bangalore, to consider, amongst other agenda items, a proposal for raising capital by issue of equity shares/warrants/any other equity linked securities, through preferential basis, subject to such approvals, as may be required under applicable laws. |
| Financial Results/Other business matters | Kindly note that a meeting of the Board of Directors of the Company will be held on Tuesday, the 30th June 2020, at the Corporate Office of the Company at Tower Block, Unity Building Complex, No. 3, Mission Road, Bangalore - 560027, inter-alia to consider, approve and take on record the Audited Financial Results (both Standalone & Consolidated) of the Company, for the quarter and year ended on 31st March 2020.We would also like to inform you that, an Earnings Conference Call has been scheduled on Tuesday, the 30th June 2020, at 5.30 p.m. (IST), to discuss on the Company s Audited Financial Results for the quarter and year ended on 31st March 2020.The details of the Earnings Call are attached herewith. |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2020 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2020 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2020 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2020 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2021 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2022 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the unaudited financial results for the period ended Jun 30, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended September 30, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the unaudited financial results of the company for the period ended December 31, 2023 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended March 31, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended Jun 30, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the unaudited financial results for the period ended September 30, 2024 and other business matters |
| Financial Results/Other business matters | To consider and approve the financial results for the period ended December 31, 2024 and other business matters |
| Financial Results/Other business matters | Further to the intimation submitted to the Stock Exchanges dated February 05, 2025, with respect to the meeting of the Board of Directors of the Company, to be held on Thursday, February 13, 2025, inter-alia to consider, approve and take on record the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the quarter and nine months ended December 31, 2024( Unaudited Financial Results ), we would like to inform you that, the meeting would commence on Thursday, February 13, 2025 and would continue on Friday, February 14, 2025, and that the Unaudited Financial Results of the Company shall be discussed and considered by the Board on February 14, 2025. |
Share Transfers of Healthcare Global Enterprises Limited
Voting Results of Healthcare Global Enterprises Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 25-SEP-2024 | AGM | To receive, consider and adopt the Audited FinancialnStatements of the Company (including AuditednConsolidated Financial Statements) for the financial yearnended March 31, 2024, together with the Reports of thenBoard of Directors and the Auditors thereon. |
| 25-SEP-2024 | AGM | To ratify the payment of remuneration to the CostnAuditors for the financial year 2024-25. |
| 25-SEP-2024 | AGM | To appoint a Director in place of Mr. Siddharth TapaswinnPatel (DIN: 07803802), who retires by rotation and beingneligible, offers himself for re-appointment. |
| 25-SEP-2024 | AGM | To appoint a Director in place of Ms. Anjali AjaikumarnRossi, (DIN: 08057112), who retires by rotation and beingneligible, offers herself for re-appointment. |
| 08-SEP-2024 | Postal Ballot | Reappointment of Ms. Geeta Mathur (DIN: 02139552), as annIndependent Director of the Company |
| 08-SEP-2024 | Postal Ballot | Reappointment of Mr. Rajagopalan Raghavan (DIN:n03627923), as an Independent Director of the Company. |
| 28-JAN-2024 | Postal Ballot | To consider and approve amendment to the Articles ofnAssociation of the Company |
| 20-SEP-2023 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023. |
| 20-SEP-2023 | AGM | To ratify the payment of remuneration to the Cost Auditors for the financial year 2023-24. |
| 20-SEP-2023 | AGM | To appoint a Director in place of Mr Meghraj Arvindrao Gore (ￂRaj Goreￂ) (DIN:07505123), who retires by rotation and being eligible, offers himself for re-appointment. |
| 20-SEP-2023 | AGM | To appoint a Director in place of Mr. Amit Soni, (DIN: 05111144), who retires by rotation and being eligible, offers himself for re-appointment. |
| 25-JUN-2023 | Postal Ballot | To consider and approve payment of Remuneration to the Independent Directors of the Company. |
| 25-JUN-2023 | Postal Ballot | Appointment of Mr. Rajiv Maliwal, (DIN: 00869035) as an Independent Director of the Company |
| 25-JUN-2023 | Postal Ballot | To consider and approve the reappointment of Dr. B. S. Ajaikumar (DIN: 00713779) as Executive Chairman of the Company. |
| 25-JUN-2023 | Postal Ballot | To consider and approve revision in remuneration of Mr. Meghraj Arvindrao Gore (DIN: 07505123), Whole-Time Director and Chief Executive Officer of the Company. |
| 25-JUN-2023 | Postal Ballot | To consider and approve the reappointment of Mrs. Anjali Ajaikumar Rossi (DIN: 08057112) as Executive Director of the Company. |
| 29-SEP-2022 | AGM | To receive, consider and adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2022, together with the Reports of the Board of Directors and the Auditors thereon. |
| 29-SEP-2022 | AGM | To consider and approve re-appointment of B S R & Co., LLP, Chartered Accountants, as statutory auditors of the Company and to fix their remuneration |
| 29-SEP-2022 | AGM | To appoint a Director in place of Mr. Siddharth Tapaswin Patel (DIN: 07803802), who retires by rotation and being eligible, offers himself for re-appointment |
| 29-SEP-2022 | AGM | To appoint a Director in place of Ms. Anjali Ajaikumar Rossi (DIN: 08057112), who retires by rotation and being eligible, offers herself for re-appointment |
FAQs on Healthcare Global Enterprises Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.